Participants 144 174 3
autism spectrum disorder (ASD)
Participants 355 385 3
subjects diagnosed with an ASD
Participants 545 627 4
trial using oral lipoceutical glutathione (n=13) or transdermal glutathione (n=13)
Participants 628 686 4
in children, 3-13 years of age, with a diagnosis of an ASD
Participants 1371 1401 3
subjects diagnosed with an ASD
